iShares Nasdaq US Biotechnology UCITS ETF ISIN IE00BYXG2H39, WKN A2DWAW

 
Add to portfolio Watch Compare ETF profile
 
 
 
 

Current quote and strategy of iShares Nasdaq US Biotechnology UCITS ETF

Quote
EUR 5.80
XETRA
18.08.22
4.60 52 weeks low/high 6.59
52 weeks low/high
Savings plan ready
Show all offers
 
Investment strategy

The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.

 

Nasdaq Biotechnology (3)

Equity (1408) United States (254) Health Care (9) Biotech (3)
 

Risk and fees of iShares Nasdaq US Biotechnology UCITS ETF

Risk
EUR 421 m
Fund size
Fund size category

Replication

Physical (Optimized sampling)
Legal structure ETF
Strategy risk Long-only
Fund currency USD

Currency risk

Currency unhedged
Volatility 1 year (in EUR) 27.31% Risk category
Inception/ Listing Date 19 October 2017
Fees
0.35% p.a.
Total expense ratio
0.00% Compare 1.38%
Compare ( Equity )
Dividend/ Taxes
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Tax data Bundesanzeiger
Legal structure
Fund Structure Open-ended Investment Company (OEIC)
UCITS compliance Yes
Fund Provider iShares
Administrator State Street Fund Services (Ireland) Limited
Investment Advisor
Custodian Bank State Street Custodial Services (Ireland) Limited
Revision Company Deloitte
Fiscal Year End 31 May
Swiss representative BlackRock Asset Management Schweiz AG
Swiss paying agent State Street Bank International GmbH, Munich, Zurich Branch
Tax Status
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Replication, swap, securities lending
Indextype Total return index
Swap counterparty -
Collateral manager Bank of New York Mellon|Euroclear|State Street Bank|JP Morgan
Securities lending Yes
Securities lending counterparty UBS AG|Deutsche Bank AG|Goldman Sachs International|BNP Paribas Arbitrage SNC|Merrill Lynch International|Citigroup Inc|BNP Paribas SA|Societe Generale SA|JP Morgan Chase & Co|The Bank of Nova Scotia|HSBC Bank Plc|Nomura International Plc|Macquarie Bank Limited|Credit Suisse Securities (Europe) Ltd.|Barclays Bank Plc|J.P. Morgan Securities Plc|Citigroup Global Markets Ltd|Morgan Stanley & Co. International Plc|Skandinaviska Enskilda Banken AB|Barclays Capital Securities Ltd.
 
 
 

Performance of iShares Nasdaq US Biotechnology UCITS ETF

Loading...
 
 

Savings plan offers for the iShares Nasdaq US Biotechnology UCITS ETF

Select your savings amount:

 
Broker Rating Savings plan offer Brokerage fee More information
 
free of charge
free of charge
More info
 
free of charge
free of charge
More info
 
free of charge
free of charge
More info
 
free of charge
free of charge
More info
 
EUR 0.80
0.80%
free of charge
More info
Show all offers
 
 

Exposure

Below you find information about the composition of the iShares Nasdaq US Biotechnology UCITS ETF.

Top 10 Holdings
Weight of top 10 holdings
out of 353
50.94%
VERTEX PHARMACEUTICALS ORD
7.61%
GILEAD SCIENCES ORD
7.55%
AMGEN-T ORD
7.50%
REGENERON PHARMACEUTICALS ORD
6.74%
MODERNA INC ORD
6.00%
ASTRAZENECA ADR REP 1 ORD
3.93%
SEAGEN INC ORD
3.45%
BIOGEN INC
3.17%
ILLUMINA ORD
3.05%
HORIZON THERAPEUTICS PUBLIC LIMITED ORD (IRELAND)
1.94%
Countries
United States
80.82%
United Kingdom
4.08%
Ireland
3.71%
Germany
1.71%
Other
9.68%
Show more
Sectors
Health Care
97.60%
Other
2.40%
As of 30/06/2022
 
 

Description of iShares Nasdaq US Biotechnology UCITS ETF

The iShares Nasdaq US Biotechnology UCITS ETF invests in stocks with focus Biotech, Health Care, United States. The dividends in the fund are reinvested (accumulating).

The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most relevant index constituents (sampling technique). The iShares Nasdaq US Biotechnology UCITS ETF has 421m Euro assets under management. The ETF is older than 3 years and is domiciled in Ireland.
 

Look for similar ETFs

Interesting ETF investment guides

 
 

Returns of iShares Nasdaq US Biotechnology UCITS ETF

Returns in years
Loading...
Returns in periods
Loading...
 
Monthly returns in a heat map
Loading...
 
 

Listings of iShares Nasdaq US Biotechnology UCITS ETF

Loading...
 

Rolling 1 year volatility of iShares Nasdaq US Biotechnology UCITS ETF

Loading...
 
Volatility 1 year Volatility 3 years Volatility 5 years
27.31% 28.22% -
Return per risk 1 years Return per risk 3 years Return per risk 5 years
-0.33 0.40 -

Track your ETF strategies online

 
— Data provided by Trackinsight, etfinfo, Xignite Inc. and justETF GmbH.

All quotes are 15 minutes delayed stock exchange quotes or NAVs (=daily published by fund provider).Returns include dividend payments. There is no warranty for completeness, accuracy and correctness for the displayed information.